Brain Function Monitor Assesses Anesthetized Patients
By HospiMedica International staff writers Posted on 11 Oct 2021 |
Image: The NeuroSense NS-901 monitor (Photo courtesy of NeuroWave Systems)
A novel brain function monitor simultaneously provides independent indices of anesthetic effects for each side of the brain.
The NeuroWave Systems (Beachwood, OH, USA) NeuroSense NS-901 monitor displays bi-lateral wavelet anesthetic value for central nervous system (WAVCNS) values, thus quantifying the hypnotic effect of anesthetics for each side of the brain independently. Unlike monitoring a single index--derived from one or both hemispheres--independent bilateral monitoring allows for greater inter-hemispheric reproducibility, providing clinicians with a tool that can be used to spot hemispheric differences resulting from underlying pathologies or unrecognized artifacts.
Features include raw electroencephalograph (EEG) signals and processed EEG parameters, with automated annotations, markers, and signal quality indicators; high-resolution bilateral density spectral array and suppression ratios; automated artifact detection and removal; electro-surgical and cardiac defibrillation filtering; discernment between consciousness and unconsciousness states; review capability for both EEG tracings and processed data trends; and an intuitive touch-screen interface and case review archive, with all data transferrable to USB drive in EDF+ format.
“Our NeuroSense monitors have successfully been used in Europe over the last decade,” said Tatjana Zikov, President of NeuroWave Systems. “This next generation brain function monitor offers unique features to this space, such as an instant response, individual anesthetic depth index for each brain side, linear response to increasingly deep anesthesia, and superior discrimination between consciousness and unconsciousness.”
NeuroWave Systems is also pioneering novel systems that will automate anesthesia and sedation delivery, using vertically integrated, proprietary infusion pumps with clinically tested closed-loop control algorithms and state-of-the-art signal processing of brain waves so as to achieve continuous, automated drug delivery, based on reliable assessment of the patient brain state.
Related Links:
NeuroWave Systems
The NeuroWave Systems (Beachwood, OH, USA) NeuroSense NS-901 monitor displays bi-lateral wavelet anesthetic value for central nervous system (WAVCNS) values, thus quantifying the hypnotic effect of anesthetics for each side of the brain independently. Unlike monitoring a single index--derived from one or both hemispheres--independent bilateral monitoring allows for greater inter-hemispheric reproducibility, providing clinicians with a tool that can be used to spot hemispheric differences resulting from underlying pathologies or unrecognized artifacts.
Features include raw electroencephalograph (EEG) signals and processed EEG parameters, with automated annotations, markers, and signal quality indicators; high-resolution bilateral density spectral array and suppression ratios; automated artifact detection and removal; electro-surgical and cardiac defibrillation filtering; discernment between consciousness and unconsciousness states; review capability for both EEG tracings and processed data trends; and an intuitive touch-screen interface and case review archive, with all data transferrable to USB drive in EDF+ format.
“Our NeuroSense monitors have successfully been used in Europe over the last decade,” said Tatjana Zikov, President of NeuroWave Systems. “This next generation brain function monitor offers unique features to this space, such as an instant response, individual anesthetic depth index for each brain side, linear response to increasingly deep anesthesia, and superior discrimination between consciousness and unconsciousness.”
NeuroWave Systems is also pioneering novel systems that will automate anesthesia and sedation delivery, using vertically integrated, proprietary infusion pumps with clinically tested closed-loop control algorithms and state-of-the-art signal processing of brain waves so as to achieve continuous, automated drug delivery, based on reliable assessment of the patient brain state.
Related Links:
NeuroWave Systems
Latest Critical Care News
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration
- Preventive PCI for High-Risk Coronary Plaques Reduces Cardiac Events
- AI Diagnostic Tool Guides Rapid Diagnosis and Prediction of Sepsis
- World's First AI-Powered Sepsis Alert System Detects Sepsis in One Minute